Article Details
Retrieved on: 2024-02-13 17:10:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche halts agreement with Repare Therapeutics to develop and commercialize camonsertib just weeks after triggering a $40 million milestone ...
Article found on: www.pharmexec.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here